Frequency of IFN-γ producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis

Vaccine

Volumn 23, Issue 48-49, 2005, Pages 5526-5532

  Logan, Karen E ^a   Chambers, Mark A ^a   Hewinson, R Glyn ^a   Hogarth, Philip J ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Prime boost; Tuberculosis; Vaccine

Indexed keywords

ANTIGEN; BCG VACCINE; GAMMA INTERFERON; RECOMBINANT ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; IMMUNITY; IMMUNOSTIMULATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BCG VACCINE; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; STATISTICS; VACCINES, DNA;

EID: 27744475648     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.037     Document Type: Article

References (33)

1. B.R. Bloom, and P.E. Fine The BCG experience: implications for future vaccines against tuberculosis B.R. Bloom Tuberculosis: pathogenesis, protection and control 1994 ASM Press Washington, DC 531 557
2. R.G. Hewinson, H.M. Vordermeier, and B.M. Buddle Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics Tuberculosis (Edinb) 83 1-3 2003 119 130
3. I.M. Orme, D.N. McMurray, and J.T. Belisle Tuberculosis vaccine development: recent progress Trends Microbiol 9 3 2001 115 118
4. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J Exp Med 178 6 1993 2243 2247
5. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J Exp Med 178 6 1993 2249 2254
6. T.H. Ottenhoff, D. Kumararatne, and J.L. Casanova Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria Immunol Today 19 11 1998 491 494
7. R.A. Taha, T.C. Kotsimbos, Y.L. Song, D. Menzies, and Q. Hamid IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis Am J Respir Crit Care Med 155 3 1997 1135 1139
8. S.G. Rhodes, N. Palmer, S.P. Graham, A.E. Bianco, R.G. Hewinson, and H.M. Vordermeier Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis Infect Immun 68 9 2000 5393 5400
9. M.A. Skinner, A.J. Ramsay, G.S. Buchan, D.L. Keen, C. Ranasinghe, and L. Slobbe A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis Immunology 108 4 2003 548 555
10. I.S. Leal, B. Smedegard, P. Andersen, and R. Appelberg Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation Immunology 104 2 2001 157 161
11. H.M. Vordermeier, M.A. Chambers, P.J. Cockle, A.O. Whelan, J. Simmons, and R.G. Hewinson Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis Infect Immun 70 6 2002 3026 3032
12. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129
13. H.J. Mollenkopf, L. Grode, J. Mattow, M. Stein, P. Mann, and B. Knapp Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis Infect Immun 72 11 2004 6471 6479
14. C.G. Feng, U. Palendira, C. Demangel, J.M. Spratt, A.S. Malin, and W.J. Britton Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guèrin against tuberculosis Infect Immun 69 6 2001 4174 4176
15. H. McShane, R. Brookes, S.C. Gilbert, and A.V. Hill Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis Infect Immun 69 2 2001 681 686
16. A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T.H. Ottenhoff, and W. Dalemans Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting Infect Immun 69 5 2001 3041 3047
17. M.A. Skinner, B.M. Buddle, D.N. Wedlock, D. Keen, G.W. de Lisle, and R.E. Tascon A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Infect Immun 71 9 2003 4901 4907
18. H.M. Vordermeier, S.G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, and A.V. Hill Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guèrin Immunology 112 3 2004 461 470
19. J.C. Ferraz, E. Stavropoulos, M. Yang, S. Coade, C. Espitia, and D.B. Lowrie A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice Infect Immun 72 12 2004 6945 6950
20. L. Brandt, Y.A. Skeiky, M.R. Alderson, Y. Lobet, W. Dalemans, and O.C. Turner The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs Infect Immun 72 11 2004 6622 6632
21. D.L. Woodland Jump-starting the immune system: prime-boosting comes of age Trends Immunol. 25 2 2004 98 104
22. Hogarth PJ, Logan KE, Vordermeier HM, Singh M, Hewinson GH, Chambers MA. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3019c - a member of the esat-6 gene family. Vaccine 2005;23:2557-2564.
23. J. Gallagher, and D.M. Horwill A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis J Hyg (Lond) 79 1 1977 155 160
24. R.L. Skjot, I. Brock, S.M. Arend, M.E. Munk, M. Theisen, and T.H. Ottenhoff Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family Infect Immun 70 10 2002 5446 5453
25. M. Vordermeier, A.O. Whelan, and R.G. Hewinson Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes Infect Immun 71 4 2003 1980 1987
26. J.K. Kolls, and A. Linden Interleukin-17 family members and inflammation Immunity 21 4 2004 467 476
27. M. Martin, S.M. Michalek, and J. Katz Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A Infect Immun 71 5 2003 2498 2507
28. T.K. Means, B.W. Jones, A.B. Schromm, B.A. Shurtleff, J.A. Smith, and J. Keane Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses J Immunol 166 6 2001 4074 4082
29. K.A. Heldwein, M.D. Liang, T.K. Andresen, K.E. Thomas, A.M. Marty, and N. Cuesta TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG J Leukoc Biol 74 2 2003 277 286
30. J.V. Brooks, A.A. Frank, M.A. Keen, J.T. Bellisle, and I.M. Orme Boosting vaccine for tuberculosis Infect Immun 69 4 2001 2714 2717
31. B.L. Freidag, G.B. Melton, F. Collins, D.M. Klinman, A. Cheever, and L. Stobie CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis Infect Immun 68 5 2000 2948 2953
32. J.L. Flynn, M.M. Goldstein, K.J. Triebold, J. Sypek, S. Wolf, and B.R. Bloom IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection J Immunol 155 5 1995 2515 2524
33. B.M. Buddle, D.N. Wedlock, N.A. Parlane, L.A. Corner, G.W. De Lisle, and M.A. Skinner Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination Infect Immun 71 11 2003 6411 6419